Study suggests positive airway pressure therapy could reduce COPD patient hospitalizations 

Generics |  News | 1 Comment | 11 Jul, 2017

Singapore - COPD hospitalizations are at an all-time high. The 30-day readmission rate for patients ranges from 20-39 percent, with related healthcare costs at an estimated $50 billion...Read more

Japanese regulators grant additional approval for the sale of Ipsen's rare cancer drug in Japan

Generics |  News | 1 Comment | 04 Jul, 2017

Bringing in much needed relief for millions of gastroenteropancreatic neuroendocrine cancer patients, the Japanese regulators have approved the sale of the drug Somatuline by Teijin pharma ...Read more

Taiwan Pharma Association opens new office in Malaysia

Generics |  News | 0 Comment | 09 Jun, 2017

Singpaore: In a bid to strengthen trade between two countries, the Taiwan Pharmaceutical Manufacturer’s Association has opened a New Southbound office in Kuala Lumpur, Malaysia. The a...Read more

Astellas prostrate cancer drug gets EU nod

Generics |  News | By BioSpectrum Bureau  | 0 Comment | 25 Jun, 2013

Singapore: The European Commission has approved Xtandi (enzalutamide) capsules for the treatment of men with metastatic castration-resistant prostate cancer, whose disease has progressed on...Read more

Sanofi, Carlyle to buy Elder Pharma for $450 mn

Generics |  News | By BioSpectrum Bureau  | 0 Comment | 25 Jul, 2013

Singapore: Sanofi's India unit and Carlyle group are in talks to buy the domestic drug formulation business of Indian drug major Elder Pharmaceuticals in a deal worth $400-to-450 million, a...Read more

Gilead's cancer drug under FDA scrutiny

Generics |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 15 Mar, 2016

Singapore: US Food and Drug Administration has raised alarm for Gilead Science's cancer medicine Zydelig (idelalisib) due to incoming reports of an increased rate of adverse events, includi...Read more

US FDA seeks inputs on its generic drug amendments

Generics |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 04 Sep, 2012

Singapore: On July 9, 2012, the Generic Drug User Fee Amendments of 2012 (GDUFA) was enacted by the US. The Food and Drug Administration (FDA) has now called for an industry meet to gather ...Read more

Lupin gets FDA nod for generic Ortho Tri-cyclen Lo Tablets

Generics |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 05 Jul, 2012

Mumbai: Mumbai-based pharma major Lupin's subsidiary, Lupin Pharmaceuticals, has received approval for its Norgestimate and Ethinyl Estradiol Tablets, 0.18 mg/0.025 mg, 0.215 mg/0.025 mg, a...Read more

FDA approves Sun Pharma's generic Prandin

Generics |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 12 Jul, 2013

Singapore: The US Food and Drug Administration (FDA) has given its finally approval to India's Sun Pharmaceutical Industries for releasing its diabetes generic Prandin. Making the announce...Read more

Cipla, Alembic contest Indian drug pricing in court

Generics |  News | By BioSpectrum Bureau  | 0 Comment | 17 Jul, 2013

Singapore: Miffed at Indian government's move to slash prices of essential medicines through the new drug pricing policy, drug makers Cipla and Alembic have now moved court. The Indian gov...Read more

Indian drug dealers worried about $1.69 bn old stocks

Generics |  News | By BioSpectrum Bureau  | 0 Comment | 02 Aug, 2013

New Delhi: Ahead of the Drug Price Control Order (DPCO) to revise drug prices that came into effect on July 29, medicine wholesalers and retailers have warned of many repercussions. The mos...Read more

First generic versions of Cymbalta receive FDA nod

Generics |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 13 Dec, 2013

Singapore: US Food and Drug Administration has approved the first generic versions of Cymbalta (duloxetine delayed-release capsules), a prescription medicine used to treat depression and ot...Read more

Takeda close to releasing Norovirus vaccine

Generics |  News | By BioSpectrum Bureau  | 0 Comment | 08 Jul, 2013

Singapore: Japan's drug major Takeda Pharmaceutical has said that they are set to finish the early stage human studies on a vaccine against norovirus, by the end of this year. Takeda's vacc...Read more

Daiichi Sankyo's subsidiary launches four new generic drugs

Generics |  News | By BioSpectrum Bureau  | 0 Comment | 18 Jun, 2015

Daiichi Sankyo Company Limited has announced that on Friday, June 19, its generics subsidiary, Daiichi Sankyo Espha, will launch seven new generic drugs with four new active ingredients. T...Read more

US FDA extends timeline for generic drug approval

Generics |  News | By BioSpectrum Bureau  | 0 Comment | 29 Oct, 2012

Singapore: In a recent move, the US Food and Drug Administration (FDA) has decided to extend the timeline for granting tentative approval to generic drug applications. The timelines of appl...Read more

FDA approves generic versions of Plavix

Generics |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 18 May, 2012

Singapore: The US Food and Drug Administration has approved generic versions of the blood thinning drug Plavix (clopidogrel bisulfate), which helps reduce the risk of heart attack and strok...Read more

FDA finds hair from human arm in Ranbaxy drugs

Generics |  News | By BioSpectrum Bureau  | 0 Comment | 19 Sep, 2013

Singapore: The US FDA released a set of further current good manufacturing practices (cGMP) violations that have been noticed at leading Indian drug maker Ranbaxy's Mohali unit. As per the ...Read more

TWi Pharma launches generic version of appetite loss drug

Generics |  News | By BioSpectrum Bureau  | 0 Comment | 29 Jul, 2015

Singapore: Taiwan based TWi Pharmaceuticals, has launched generic version of Par Pharmaceutical's Megace ES (megestrol acetate oral suspension) 625mg/5ml after the United States District Co...Read more